Continuing Medical Education | CID 2802
Presented by UH Harrington Heart & Vascular Institute
Sponsored by Case Western Reserve University School of Medicine
VIRTUAL OR IN-PERSON EVENT
In-Person at Tinkham Veale University Center
11028 Bellflower Road Cleveland, OH 44106
Breakfast and Registration | 7 - 8 a.m.
CME Sessions | 8 a.m. – 2:45 p.m. (breakfast & lunch provided for onsite attendees)
OVERVIEW
This symposium will provide an in-depth review of current advances in the care of complex patients with cardiovascular disease. Topics cover guideline- and evidence-based strategies to lower cardiovascular risk in patients, optimal diagnostic approaches to help guide cardiovascular therapies, emerging treatments for complex patients with structural heart disease, arrhythmias and heart failure, as well as novel heart and vascular devices and technologies. Practitioners should be able to incorporate many of the tips and tools from this case-based program into their daily practice.
WHO SHOULD ATTEND
The intended audience for this activity are cardiologists, cardiovascular subspecialists, vascular surgeons, internists, family practitioners, nurse practitioners and physician assistants.
Saturday, October 21, 2023
PROGRAM AGENDA
7 – 7:55 a.m. | Registration and Continental Breakfast
7:55 – 8 a.m. | Introduction and Welcome
Dr. Mehdi Shishehbor and Dr. Sanjay Rajagopalan
PLENARY SESSION
Moderator: Dr. Daniel Simon
8 – 8:25 a.m. | Targeting Inflammation in Atherosclerosis | Dr. Peter Libby
8:25 – 8:30 a.m. | Discussion and Q&A
TRACK ONE: PREVENTION
Moderator: Dr. Claire Sullivan
Panel: Dr. Mirela Dobre, Dr. Goutham Rao
8:30 – 8:45 a.m. | The Cardiovascular-Kidney-Metabolic (CKM) Health Initiative: A Paradigm for 21st Century Preventive Cardiovascular Care | Dr. Janani Rangaswami
8:45 – 9 a.m. | New Frontiers in Hypertension Management | Dr. Jackson Wright
9 – 9:10 a.m. | Discussion and Q&A
TRACK TWO: ELECTROPHYSIOLOGY
Moderator: Dr. Judith Mackall
Panel: Dr. Ivan Cakulev, Dr. Sergio Thal
9:10 – 9:25 a.m. | Should AF Ablation Be First Line Therapy for Treatment of Atrial Fibrillation? | Dr. Hugh Calkins
9:25 – 9:40 a.m. | Can Drugs or Lifestyle Modifications Really Impact Atrial Fibrillation Occurrence or Recurrence? | Dr. David Frankel
9:40 – 9:50 a.m. | Discussion and Q&A
9:50 – 10:20 a.m. | COFFEE & EXHIBITS
PLENARY SESSION: CONGENITAL
Moderator: Dr. Phillip Barger
10:20 – 10:45 a.m. | Management of Adult Congenital Heart Disease | Dr. Joseph Kay
10:45 – 10:55 a.m. | Discussion and Q&A
TRACK THREE: HEART FAILURE
Moderator: Dr. Thomas O’Neill
Panel: Dr. Michael Zacharias, Dr. Robert Montgomery
10:55 – 11:10 a.m. | Exercise and Sports Participation with Hypertrophic Cardiomyopathy: A Practical Approach | Dr. Bradley Lander
11:10 – 11:25 a.m. | What You Should Know About Cardio-Oncology | Dr. Zeeshan Hussain
11:25 – 11:35 a.m. | Discussion and Q&A
TRACK FOUR: INTERVENTIONAL & STRUCTURAL HEART
Moderator: Dr. Farshad Forouzandeh
Panel: Dr. Charles O’Shaughnessy, Dr. Marwan Nasif, Dr. Kelsey Gray
11:35 – 11:50 a.m. | Hybrid Revascularization and MIDCABG | Dr. Pablo Ruda Vega
11:50 a.m. – 12:05 p.m. | CTO Revascularization in 2023 | Dr. Paul Poommipanit
12:05 – 12:15 p.m. | Discussion and Q&A
12:15 – 1:30 p.m. | LUNCH & EXHIBITS
12:50 – 1:30 p.m. Break Out Sessions – Sonographers & Nurses
Sonography: Echocardiography and the HCM Patient: A Collaborative Interdisciplinary Team Approach | Raymond Musarra MBA, ACS, FASE and Diane Donato, BSN, RN B-C
Nursing: Basics for Clinical Trial Results Interpretation
TRACK FIVE: IMAGING
Moderators: Dr. Imran Rashid, Dr. Andres Schuster
1:30 – 1:45 p.m. | Echocardiography in the New Millennia | Dr. Roberto Lang
1:45 – 2:00 p.m. | Novel MRI Pulse Sequences and Techniques to Improve the Clinical Utility of CMR Imaging | Dr. Michael Salerno
2 – 2:10 p.m. | Discussion and Q&A
PLENARY SESSION
Moderator: Dr. Sanjay Rajagopalan
2:10 – 2:35 pm | Clonal Hematopoiesis | Dr. Pradeep Natarajan
2:35 – 2:40 pm | Discussion and Q&A
2:40 – 2:45 pm | Closing Remarks
ACTIVITY DIRECTORS
Sanjay Rajagopalan, MD, FACC, FAHA, MBA
Chief, Cardiovascular Medicine, UH Harrington Heart & Vascular Institute
Herman K. Hellerstein MD, Professor of Cardiovascular Research
Mehdi H. Shishehbor, DO, MPH, PhD
President, UH Harrington Heart & Vascular Institute
Angela and James Hambrick Chair in Innovation
PLENARY SPEAKERS
Joseph Kay, MD, FACC
University of Colorado
Peter Libby, MD
Brigham and Women's Hospital
Pradeep Natarajan, MD, MSc
Massachusetts General Hospital
GUEST SPEAKERS
Hugh Calkins, MD, FHRS, FACC, FAHA, FESC
John Hopkins Medical Center
David Frankel, MD
Hospital of the University of Pennsylvania
Roberto M. Lang, MD, FASE, FACC, FESC, FAHA, FRCP
University of Chicago Medicine
Michael Salerno, MD, PhD
Stanford University
UNIVERSITY HOSPITALS SPEAKERS AND PANELISTS
* denotes planning committee member
Philip M. Barger, MD MSc *
Director, Adult Congenital Heart Disease Center
Ivan Cakulev, MD *
Medical Director, Non-Cardiac Telemetry
Mirela Dobre, MD, MPH
Division of Nephrology and Hypertension
Farshad Forouzandeh, MD, PhD, FACC, FSCAI *
Interventional Cardiology
Kelsey Gray, MD
Division of Cardiac Surgery
Zeeshan Hussain, MD
Director, Cardio-Oncology Program
Bradley Lander, MD
Director, Sports Cardiology Center
Judith Mackall, MD *
Director, Cardiac Device Clinic
Director, Cardiac Electrophysiology Fellowship
Spitz Master Clinician in Cardiology
Robert Montgomery, MD
Advanced Heart Failure and Transplant Cardiology
Marwan Nasif, MD, MPH
Director, Cardiac Catheterization Lab at UH Lake West Medical Center
Ian J. Neeland, MD, FAHA, FACC *
Director, Center for Cardiovascular Prevention
Director, Translational Science Unit
Co-Director, Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)
Thomas J O’Neill IV, MD, PhD *
Advanced Heart Failure and Transplant Cardiology
Charles O’Shaughnessy, MD
Medical Director, Cardiac Catheterization Lab at UH Elyria Medical Center
Paul Poommipanit, MD*
Director, Coronary Chronic Total Occlusion Program
Goutham Rao, MD
Chair, Department of Family Medicine and Community Health
Division Chief, Family Medicine and Chief Clinician Experience Officer
Imran Rashid, MD, PhD, FRACP*
Director, Cardiovascular MRI
Pablo Ruda Vega, MD
System Director, Community Hospital Cardiac Surgery
Andres Schuster, MD, FACP*
System Director, Adult Echocardiography
Daniel Simon, MD
President, Academic & External Affairs and Chief Scientific Officer
Ernie and Patti Novak Distinguished Chair in Health Care Leadership
Claire Sullivan, MD *
Preventive Cardiology
Diplomat of the National Lipid Association
Sergio Thal, MD *
Director, Lead Management Program
Jackson T Wright Jr, MD, PhD
Division of Nephrology and Hypertension
Michael Zacharias, DO, FHFSA, FACC *
Associate Clinical Chief, Cardiovascular Medicine
Medical Director, Mechanical Circulatory Support and Associate Program Director
Advanced Heart Failure and Transplant Fellowship
FEES
UH and VA Employee Rate: Free
Non-UH Rates:
Physicians (in person): $150
Physicians (virtual): $75
Nurses, technicians, residents (in person): $50
Nurses, technicians, residents (virtual): $25
REGISTRATION
Register online at cwru.cloud-cme.com/cvd23
QUESTIONS?
Email medcme@case.edu
ACCREDITATION STATEMENT
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Case Western Reserve University School of Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
POLICY DISCLOSURE
The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.
This program will be supported by grants from industry. A complete list of supporters will be provided in the syllabus materials distributed at the meeting. Acceptance of funding in support of this program does not constitute endorsement of any product or manufacturer.